Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Tachycardia, Ventricular

• Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
• The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients)
• Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy
• Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia
• Venous Ethanol for Ventricular Tachycardia
• Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia
• Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation
• Treatment of an Inherited Ventricular Arrhythmia
• Etripamil Nasal Spray in Patients With Paroxysmal Supraventricular Tachycardia
• Comparison of Ventricular Tachycardia Ablation Strategies in Patients With Ischemic Cardiomyopathy
• A Trial to Compare American Heart Association (AHA) and Simple (SIM)Method to Give Adenosine to Treat Supra-ventricular Tachycardia (SVT)
• Continuation of Antiarrhythmics Following Ventricular Tachycardia Catheter Ablation
• A Clinical Trial Utilizing Dantrolene in Patients With Ventricular Arrhythmias.
• Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303
• Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection.
• Epinephrine Dose: Optimal Versus Standard Evaluation Trial
• Trial to Evaluate the Efficacy and Safety of Substrate Ablation of Monomorphic Ventricular Tachycardia
• Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302
• Effects of Carvedilol on Suppressing the Premature Ventricular Complex/Ventricular Tachycardia From Outflow Tract
• Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE 301 [Part 1 and Part 2 (The RAPID Study)]
• Impact of PREVENTIVE Substrate Ablation of Coronary Chronic Total Occlusion on Implantable cardioVerTer-Defibrillator Interventions
• Contrast ICE for Myocardial Scar in VT Ablations
• Atropine in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
• Antiarrhythmics or Ablation for Ventricular Tachycardia 2
• DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation
• Prospective Randomized Clinical Trial for Effect of Stellate Ganglion Block in Medically Refractory Ventricular Tachycardia
• Inducibility and Stability of Ventricular Tachycardia Inpatients Undergoing VT Ablation Under General Anesthesia
• Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Ischemic Ventricular Tachyarrhythmias
• INTERVENE: Indian Trial of Endocardial Ventricular Substrate Ablation to Prevent Recurrent VT Events
• Efficacy and Safety of Intranasal MSP-2017 (Etripamil) for the Conversion of PSVT to Sinus Rhythm
• Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention
• Botulinum Toxin Injection for Preventing Secondary Atrial Fibrillation in Patient With Supra-ventricular Tachyarrythmias
• Botulinum Toxin Injection to Prevent Ventricular Arrhythmias
• Remifentanil Intravenous Patient Controlled Analgesia (IVPCA) for Ablation of Idiopathic Ventricular Tachycardia
• Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation
• Trial Comparing Ablation With Medical Therapy in Patients With Ventricular Tachycardia
• Catheter Ablation Versus Antiarrhythmic Drugs for Outflow Tract Ventricular ARrhythmias
• Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention of Death
• Oral Verapamil in Acute Paroxysmal Supra Ventricular Tachycardia(PSVT) Recurrence Control
• Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation
• Pilot Study of Catheter Ablation for Ventricular Tachycardia in Patients With an Implantable Cardioverter Defibrillator
• Safety of Amiodarone and Ranolazine Together in Patients With Angina
• Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators
• Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
• Imaging With a Radio Tracer to Guide VT Ablations
• Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
• Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia
• Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias
• Ventricular Tachycardia (VT) Ablation or Escalated Drug Therapy
• Anti-arrhythmic Medication v. MRI-Merge Ablation in the Treatment of Ventricular Tachycardia
• Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias
• Clonidine to Prevent Implantable Cardiovertor Defibrillator Firing
• Intravenous n-3 Fatty Acids and Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillator (ICD)-Pacemaker
• Treatment of Ventricular Tachyarrhythmias Refractory To Shock With Beta Blockers: The SHOCK and BLOCK Trial
• Iv Amiodarone Versus Iv Procainamide to Treat Haemodynamically Well Tolerated Ventricular Tachycardia
• Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC)
• Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS
• Study Evaluating GAP-486 in Non-Sustained Ventricular Tachycardia
• Antiarrhythmics Versus Implantable Defibrillators (AVID)
• Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)
• Multicenter Unsustained Tachycardia Trial (MUSTT)